ASCO President Dr. Monica Bertagnolli is going out into local communities to find out what people with cancer and health care providers think and need. The second of these town halls was held in Sudbury, Massachusetts. In this podcast, Dr. Colin Weekes and Pastor Joel Guillemette describe the town hall and what they learned from the conversation about the role of hope and how people cope with fear of mortality.
Kidney cancer is the sixth most common cancer for men and the tenth most common cancer for women. Cancer.Net Associate Editor Brian Rini, MD, shares 4 things people need to know about kidney cancer.
Read about 4 activities that can help you build a legacy to be remembered by.
ASCO Annual Meeting 2018: Geriatric Assessment Improves Communication, Racial and Gender Differences in Cancer Treatment, and a Comparison of Cancer Treatment Costs
Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights include the effects of geriatric assessment on patient-doctor communication, treatments for advanced prostate cancer that may work better in black men, the possibility that women are undertreated for head and neck cancer, and a comparison of treatment costs for colorectal cancer between the U.S. and Canada.
TeMaya Eatmon’s friendship with a fellow breast cancer patient inspired her in ways she never imagined possible. Learn how heartbreaking loss led to a life-changing role as an advocate.
The 2018 Clinical Cancer Advances report of the American Society of Clinical Oncology has crowned an adoptive cell immunotherapy as its Advance of the Year. What is this innovative cancer treatment? What are the risks and benefits?
ASCO Annual Meeting 2017: Advances in Immunotherapy for Multiple Myeloma and Mesothelioma, and Targeted Therapies for Non-Small Cell Lung Cancer and HER2-Positive Breast Cancer
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Today’s key research highlights include CAR T-cell therapy for multiple myeloma, immune checkpoint inhibitors for mesothelioma, and targeted therapy advances for non-small cell lung cancer and HER2-positive breast cancer.
ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Here are some of today’s key research highlights, with a focus on enhancing survivors’ health.
The Importance of Palliative Care for Patients and Caregivers: News from the 2016 Palliative Care in Oncology Symposium
Research presented this weekend will highlight the importance of access to palliative care that addresses the health and well-being of patients and caregivers.